0.00425
CNBX Pharmaceuticals Inc Stock (CNBX) Forecast
The CNBX Pharmaceuticals Inc (CNBX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.5956, representing a +84,502% increase from the current price of $0.00425. The highest analyst price target is $4.6206, and the lowest is $2.5705.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNBX Price Target
Average 2.9906
(+70,266% Upside)
Long-term CNBX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about CNBX Pharmaceuticals Inc financial reports and earnings history, CNBX Pharmaceuticals Inc (CNBX) stock could reach $3.625 by 2030, $2.8368 by 2040 and $2.9466 by 2050. See the projected annual prices until 2050 of the CNBX Pharmaceuticals Inc stock below:
- CNBX Pharmaceuticals Inc (CNBX) is expected to reach an average price of $3.043 in 2035, with a high prediction of $3.963 and a low estimate of $1.5622. This indicates an $71,500% rise from the last recorded price of $0.00425.
- CNBX Pharmaceuticals Inc (CNBX) stock is projected to chart a bullish course in 2040, with an average price target of $2.7972, representing an $65,717% surge from its current level. The forecast ranges from a conservative $1.4861 to a sky-high $2.8368.
- Our analysts predict CNBX Pharmaceuticals Inc (CNBX) to jump 43,947% by 2045, soaring from $1.872 to an average price of $1.872, potentially reaching $2.605. While $1.872 is the low estimate, the potential upside is significant.
- CNBX Pharmaceuticals Inc (CNBX) stock is expected to climb by 2050, reaching an average of $2.0266, a $47,586% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.9466 and $0.5448, respectively, highlighting the market's uncertainty.
CNBX Pharmaceuticals Inc Stock (CNBX) Year by Year Forecast
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2025
CNBX Pharmaceuticals Inc Stock (CNBX) is expected to reach an average price of $3.0055 in 2025, with a high prediction of $4.6206 and a low estimate of $1.3904. This indicates an +70,618% rise from the last recorded price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
May, 2025 | $3.7707 | $2.5705 | $4.6206 | +88,622% |
June, 2025 | $3.2709 | $2.4709 | $3.8209 | +76,863% |
July, 2025 | $3.8212 | $2.741 | $3.8212 | +89,811% |
August, 2025 | $3.7901 | $3.6401 | $3.925 | +89,080% |
September, 2025 | $2.9805 | $1.3904 | $4.3904 | +70,029% |
October, 2025 | $3.6707 | $2.1905 | $4.5907 | +86,271% |
November, 2025 | $3.791 | $3.2008 | $4.0408 | +89,101% |
December, 2025 | $3.7514 | $2.4411 | $3.7912 | +88,167% |
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2026
The predicted value for CNBX Pharmaceuticals Inc (CNBX) in 2026 is set at an average of $2.9457. Estimates vary from a peak of $4.5609 to a trough of $1.3305, indicating an +69,210% surge from the present price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $3.7601 | $3.7415 | $3.895 | +88,372% |
February, 2026 | $4.3604 | $3.1603 | $4.3604 | +102.50K% |
March, 2026 | $2.8309 | $1.3605 | $4.3605 | +66,509% |
April, 2026 | $3.5861 | $2.8309 | $4.5609 | +84,279% |
May, 2026 | $3.7614 | $2.4112 | $3.7614 | +88,404% |
June, 2026 | $3.75 | $3.2615 | $3.865 | +88,135% |
July, 2026 | $3.1304 | $3.1304 | $3.7801 | +73,555% |
August, 2026 | $2.5807 | $1.3305 | $4.3305 | +60,622% |
September, 2026 | $3.5311 | $2.4808 | $4.531 | +82,986% |
October, 2026 | $3.2815 | $2.3814 | $3.7313 | +77,112% |
November, 2026 | $3.7318 | $3.0216 | $3.7318 | +87,708% |
December, 2026 | $3.5003 | $3.4503 | $3.835 | +82,260% |
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for CNBX Pharmaceuticals Inc (CNBX) is $2.8709, with a high forecast of $4.5011 and a low forecast of $1.2407. This indicates an +67,450% increase from the last price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $2.8907 | $1.3006 | $4.3006 | +67,916% |
February, 2027 | $3.5811 | $2.1008 | $4.5011 | +84,160% |
March, 2027 | $3.1516 | $2.3516 | $3.9512 | +74,054% |
April, 2027 | $3.6619 | $2.6217 | $3.7018 | +86,063% |
May, 2027 | $3.6701 | $3.6521 | $3.805 | +86,255% |
June, 2027 | $3.1706 | $1.2706 | $4.2706 | +74,503% |
July, 2027 | $2.7412 | $2.0709 | $3.1707 | +64,398% |
August, 2027 | $3.6716 | $2.7412 | $4.4712 | +86,291% |
September, 2027 | $3.632 | $2.3217 | $3.6719 | +85,360% |
October, 2027 | $3.66 | $3.6224 | $3.775 | +86,018% |
November, 2027 | $4.2406 | $3.0405 | $4.2406 | +99,678% |
December, 2027 | $2.8411 | $1.2407 | $4.2407 | +66,748% |
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2028
In 2028, CNBX Pharmaceuticals Inc (CNBX) is projected to reach an average price of $2.8111, with a high projection of $4.4413 and a low estimate of $1.1808. This indicates an +66,042% rise from the last price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $3.4415 | $2.7112 | $4.4413 | +80,877% |
February, 2028 | $3.6421 | $2.2919 | $3.6421 | +85,597% |
March, 2028 | $3.3923 | $3.1422 | $3.6425 | +79,720% |
April, 2028 | $3.4104 | $3.3604 | $3.745 | +80,144% |
May, 2028 | $2.461 | $1.2108 | $4.2108 | +57,806% |
June, 2028 | $3.5615 | $2.3611 | $4.4114 | +83,700% |
July, 2028 | $3.062 | $2.262 | $3.6119 | +71,948% |
August, 2028 | $3.6127 | $2.5322 | $3.6127 | +84,904% |
September, 2028 | $3.5803 | $3.4303 | $3.715 | +84,142% |
October, 2028 | $2.771 | $1.1808 | $4.1808 | +65,099% |
November, 2028 | $3.4615 | $1.9811 | $4.3815 | +81,347% |
December, 2028 | $3.582 | $2.9916 | $3.8316 | +84,183% |
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2029
The 2029 price forecast for CNBX Pharmaceuticals Inc Stock (CNBX) is $2.7363 on average, with a high prediction of $4.3516 and a low estimate of $1.1209. This represents an +64,283% increase from the previous price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $3.5427 | $2.2322 | $3.5825 | +83,258% |
February, 2029 | $3.5501 | $3.533 | $3.685 | +83,433% |
March, 2029 | $4.1507 | $2.9506 | $4.1507 | +97,564% |
April, 2029 | $2.7513 | $1.1509 | $4.1509 | +64,637% |
May, 2029 | $3.377 | $2.6215 | $4.3516 | +79,360% |
June, 2029 | $3.5526 | $2.2023 | $3.5526 | +83,491% |
July, 2029 | $3.54 | $3.0528 | $3.655 | +83,194% |
August, 2029 | $2.9206 | $2.9206 | $3.5702 | +68,621% |
September, 2029 | $2.3712 | $1.1209 | $4.1209 | +55,694% |
October, 2029 | $3.322 | $2.2714 | $4.3217 | +78,065% |
November, 2029 | $3.0726 | $2.1725 | $3.5223 | +72,198% |
December, 2029 | $3.5233 | $2.8128 | $3.5233 | +82,800% |
CNBX Pharmaceuticals Inc Stock (CNBX) Price Forecast for 2030
CNBX Pharmaceuticals Inc Stock (CNBX) is expected to reach an average price of $2.6764 in 2030, with a high forecast of $4.2918 and a low forecast of $1.0611. This signifies an +62,875% surge from the last price of $0.00425.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $3.2905 | $3.2405 | $3.625 | +77,323% |
February, 2030 | $2.6812 | $1.091 | $4.091 | +62,986% |
March, 2030 | $3.3718 | $1.8913 | $4.2918 | +79,237% |
April, 2030 | $2.9426 | $2.1426 | $3.742 | +69,139% |
May, 2030 | $3.4533 | $2.4128 | $3.493 | +81,154% |
June, 2030 | $3.4602 | $3.4436 | $3.595 | +81,316% |
July, 2030 | $2.9611 | $1.0611 | $4.0611 | +69,572% |
August, 2030 | $2.5319 | $1.8614 | $2.9612 | +59,473% |
September, 2030 | $3.2875 | $2.5319 | $4.2619 | +77,252% |
October, 2030 | $3.4233 | $2.1128 | $3.4632 | +80,449% |
November, 2030 | $3.45 | $3.4139 | $3.565 | +81,076% |
December, 2030 | $4.0309 | $2.8307 | $4.0309 | +94,745% |
Cap:
|
Volume (24h):